IOBT - IO Biotech, Inc.

QQQ $ 612.47 $ 0.94 (0.15 %)

DIA $ 469.99 $ 2.87 (0.61 %)

SPY $ 672.53 $ 1.04 (0.15 %)

TLT $ 91.98 $ -0.01 (-0.01 %)

GLD $ 380.44 $ -6.31 (-1.63 %)

Previous Close

$ 0.8202

Open

$ 0.78

Bid

$ 0.90 x 300

Ask

$ 0.90 x 100

Day's Range

$ 0.75 - $ 0.90

52 Week Range

$ 0.32 - $ 2.79

Volume

71,028,467

Average Volume

Market Cap

54.04M

Beta (5Y Monthly)

$ 1.15

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	03-05-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-11-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-14-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	03-31-2022	12-31-2021	10-K
16	12-17-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

IO Biotech Phase 3: Cylembio Plus KEYTRUDA...
10/20/2025 06:48:42

Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0...

12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

TD Cowen Downgrades IO Biotech to Hold
09/30/2025 15:15:19

TD Cowen analyst Yaron Werber downgrades IO Biotech (NASDAQ:IOBT) from Buy to Hold.

crude-oil-falls-sharply-carnival-posts-upbeat-earnings

Crude Oil Falls Sharply; Carnival Posts Up...
09/29/2025 17:14:55

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded do...

12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

HC Wainwright & Co. Downgrades IO Biotech ...
09/29/2025 16:24:17

HC Wainwright & Co. analyst Emily Bodnar downgrades IO Biotech (NASDAQ: IOBT) from Buy to Neutral.

nasdaq-jumps-150-points-us-pending-home-sales-rise

Nasdaq Jumps 150 Points; US Pending Home S...
09/29/2025 14:11:58

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

IO Biotech Plans To Design New Registratio...
09/29/2025 11:16:40

FDA recommends that IO Biotech not submit a Biologics License Application (BLA) based on the data from the IOB-013 clinical tri...

IO Biotech Issues Update On Regulatory Pat...
09/29/2025 11:15:34

FDA recommends that IO Biotech not submit a Biologics License Application (BLA) based on the data from the IOB-013 clinical tri...

IO Biotech To Present Phase 3 And Final Ph...
09/23/2025 12:06:56

Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine p...

12 Health Care Stocks Moving In Friday's I...
08/15/2025 17:07:19

IO Biotech Q2 EPS $(0.40) Misses $(0.35) E...
08/14/2025 20:35:37

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) ...

12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

Morgan Stanley Maintains Overweight on IO ...
08/12/2025 12:27:09

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target fro...

12 Health Care Stocks Moving In Monday's I...
08/11/2025 17:06:46

io-biotechs-combo-therapy-for-skin-cancer-falls-just-short-eyes-fda-talks-later-this-year

IO Biotech's Combo Therapy For Skin Cancer...
08/11/2025 14:09:05

IO Biotech's Phase 3 trial showed Cylembio plus Keytruda improved progression-free survival in advanced melanoma across mos...

Trading Halt: Halt status updated at 8:25:...
08/11/2025 12:25:09

IO Biotech Announces Topline Results From ...
08/11/2025 12:10:21